.RESEARCH EMPHASIZE.06 August 2024.
A large randomized controlled test along with cisgender women highlights the difficulties of obedience to a day-to-day oral preexposure prevention regiment as well as shows that twice-yearly shot of lenacapavir can easily maintain helpful HIV deterrence degrees over 6 months.